Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate that platelet-derived repairing factors are effective and safe in the treatment of muscular lesion grade 2 or 3, a Phase II, open-label, single arm, single centre has been designed. Sample size will be 25.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01381770
Study type Interventional
Source IRCCS Policlinico S. Matteo
Contact
Status Completed
Phase Phase 2
Start date September 2010
Completion date May 2013